Location History:
- Midland, MI (US) (1995 - 2001)
- Issaquah, WA (US) (2001 - 2022)
- Seattle, WA (US) (2017 - 2022)
Company Filing History:
Years Active: 1995-2025
Areas of Expertise:
Title: The Innovative Journey of Mark W. Rixon: Pioneering Immunomodulatory Proteins
Introduction: Mark W. Rixon, based in Issaquah, WA, is a remarkable inventor with an impressive portfolio of 42 patents. His work primarily focuses on immunomodulatory proteins, contributing significantly to the field of biomedical innovation.
Latest Patents: Among his recent groundbreaking patents are those related to APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof. These innovative proteins exhibit neutralizing activity against BAFF and APRIL heterotrimers. The patents describe immunomodulatory proteins, including variant domains of Transmembrane Activator and CAML Interactor (TACI) and TACI-Fc fusion proteins. Furthermore, the patents encompass nucleic acid molecules encoding these proteins, underscoring their therapeutic utility for various immunological diseases, disorders, and conditions. The compositions and methods detailed offer significant insights into making and utilizing these proteins effectively.
Career Highlights: Mark W. Rixon has held notable positions in influential companies such as Zymogenetics, Inc. and The Dow Chemical Company. His work has enhanced the understanding of immunomodulation and has the potential to lead to groundbreaking treatments.
Collaborations: Throughout his career, Mark has collaborated with distinguished colleagues, including Scott R. Presnell and Jane A. Gross. These collaborations have fostered a conducive environment for innovation and development in the biomedical field.
Conclusion: Mark W. Rixon's contributions to the field of immunology and his extensive patent portfolio reflect his dedication to advancing medical science. His innovations in immunomodulatory proteins promise to pave the way for new therapeutic strategies in treating a variety of immunological conditions.